New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects

Publisher： John Wiley & Sons Inc

E-ISSN： 1526-4637|16|8|1540-1550

ISSN： 1526-2375

Source： PAIN MEDICINE, Vol.16, Iss.8, 2015-08, pp. : 1540-1550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Opioid‐Induced Constipation

PAIN MEDICINE, Vol. 16, Iss. S1, 2015-10 ,pp. : S16-S21

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient preference with respect to QoL and reduction in opioid‐induced constipation (OIC) after treatment with prolonged‐release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study]

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 68, Iss. 11, 2014-11 ,pp. : 1364-1375

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

By Simpson K. Leyendecker P. Hopp M. Müller-Lissner S. Löwenstein O. De Andrés J. Troy Ferrarons J. Bosse B. Krain B. Nichols T. Kremers W. Reimer K.

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3503-3512

Informa Healthcare

Access to resources Recommend Favorite

The Bowel Function Index: a new validated scale for assessing opioid-induced constipation

By Ducrotté Philippe Caussé Christian

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 457-466

Informa Healthcare

Access to resources Recommend Favorite

Risk Predictors of Opioid‐Induced Critical Respiratory Events in Children: Naloxone Use as a Quality Measure of Opioid Safety

PAIN MEDICINE, Vol. 15, Iss. 12, 2014-12 ,pp. : 2139-2149

John Wiley & Sons Inc

Access to resources Recommend Favorite